Zfra restores memory deficits in Alzheimer’s disease triple-transgenic mice by blocking the aggregation of TPC6AΔ, SH3GLB2, Tau, and amyloid β, and reducing inflammatory NF-κB activation (Lee et al., 2017). Here, NFKB1 is linked to Alzheimer disease.